Transition to Ductal Stenting for Single Ventricle Patients Led to Improved Survival: An Institutional Case Series

Abstract

Background:

The use of systemic-to-pulmonary shunts (SPS) in neonates with single ventricle heart defects and ductal-dependent pulmonary blood flow (ddPBF) was historically associated with high morbidity and mortality at our center. As a result, we transitioned to the preferential use of ductus arteriosus stents (DS) when feasible. This report describes our initial results with this strategy.

Methods:

A single-center study of single ventricle patients that received DS or SPS from 2015 to 2019 was performed to assess whether DS was associated with decreased in-hospital morbidity and increased survival to stage II palliation.

Results:

A total of 34 patients were included (DS = 11; SPS = 23). Underlying cardiac anomalies were similar between groups and included pulmonary atresia, unbalanced atrioventricular septal defect, and tricuspid atresia. Procedure success was similar between groups (82% vs 83%). Two DS patients were converted to SPS, due to ductal vasospasm or pulmonary artery obstruction, and four SPS patients required surgical shunt revision. In DS patients, postprocedure mechanical ventilation duration was shorter (one vs three days, P = .009) and fewer required postprocedure extracorporeal membrane oxygenation (9% vs 39%, P = .11). A higher proportion of DS patients survived to stage II palliation (100% vs 64%, P = .035), and the probability of one-year survival was higher in DS patients (100% vs 61%, P = .02).

Conclusions:

At our center, patients with single ventricle heart defects and ddPBF that received DS experienced reduced in-hospital morbidity and increased survival to stage II palliation compared to SPS.

Keywords

CHD univentricular heart congenital heart disease (CHD)congenital heart surgery functionally univentricular heart neonate outcomes (includes mortality morbidity)patent ductus arteriosus (patent arterial duct)pulmonary atresia with intact ventricular septum tricuspid atresia

Get full access to this article

View all access options for this article.

References

McMullan

Permut

Jones

Johnston

Rubio

. Modified Blalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions with inadequate pulmonary blood flow. J Thorac Cardiovasc Surg. 2014;147(1):397–401.

Alwi

Choo

Latiff

Kandavello

Samion

Mulyadi

. Initial results and medium-term follow-up of stent implantation of patent ductus arteriosus in duct-dependent pulmonary circulation. J Am Coll Cardiol. 2004;44(2):438–445.

Alsoufi

Gillespie

Mori

Clabby

Kanter

Kogon

. Factors affecting death and progression towards next stage following modified Blalock-Taussig shunt in neonates. Eur J Cardiothorac Surg. 2016;50(1):169–177.

Petrucci

O’Brien

Jacobs

Manning

Eghtesady

. Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure. Ann Thorac Surg. 2011;92(2):642–651; discussion 651-2.

Vitanova

Leopold

von Ohain

, et al. Reasons for failure of systemic-to-pulmonary artery shunts in neonates. Thorac Cardiovasc Surg. 2019;67(1):2–7.

Myers

Ghanayem

Cao

, et al. Outcomes of systemic to pulmonary artery shunts in patients weighing less than 3 kg: analysis of shunt type, size, and surgical approach. J Thorac Cardiovasc Surg. 2014;147(2):672–677.

Alsoufi

Gillespie

Kogon

, et al. Results of palliation with an initial modified Blalock-Taussig shunt in neonates with single ventricle anomalies associated with restrictive pulmonary blood flow. Ann Thorac Surg. 2015;99(5):1639–1646; discussion 1646-7.

McKenzie

Khan

Samayoa

, et al. The Blalock-Taussig shunt revisited: a contemporary experience. J Am Coll Surg. 2013;216(4):699–704; discussion 704-6.

Guzzetta

Foster

Mruthinti

Kilgore

Miller

Kanter

. In-hospital shunt occlusion in infants undergoing a modified Blalock-Taussig shunt. Ann Thorac Surg. 2013;96(1):176–182.

10.

Gibbs

Rothman

Rees

Parsons

Blackburn

Ruiz

. Stenting of the arterial duct: a new approach to palliation for pulmonary atresia. Br Heart J. 1992;67(3):240–245.

11.

Michel-Behnke

Akintuerk

Thul

Bauer

Hagel

Schranz

. Stent implantation in the ductus arteriosus for pulmonary blood supply in congenital heart disease. Catheter Cardiovasc Interv. 2004;61(2):242–252.

12.

Bentham

Zava

Harrison

, et al. Duct stenting versus modified Blalock-Taussig shunt in neonates with duct-dependent pulmonary blood flow: associations with clinical outcomes in a multicenter national study. Circulation. 2018;137(6):581–588.

13.

Boucek

Qureshi

Goldstein

Petit

Glatz

. Blalock-Taussig shunt versus patent ductus arteriosus stent as first palliation for ductal-dependent pulmonary circulation lesions: a review of the literature. Congenit Heart Dis. 2019;14(1):105–109.

14.

Mallula

Vaughn

El-Said

Lamberti

Moore

. Comparison of ductal stenting versus surgical shunts for palliation of patients with pulmonary atresia and intact ventricular septum. Catheter Cardiovasc Interv. 2015;85(7):1196–1202.

15.

Amoozgar

Cheriki

Borzoee

, et al. Short-term result of ductus arteriosus stent implantation compared with surgically created shunts. Pediatr Cardiol. 2012;33(8):1288–1294.

16.

Meadows

Qureshi

Goldstein

, et al. Comparison of outcomes at time of superior cavopulmonary connection between single ventricle patients with ductal-dependent pulmonary blood flow initially palliated with either Blalock-Taussig shunt or ductus arteriosus stent: results from the congenital catheterization research collaborative. Circ Cardiovasc Interv. 2019;12(10):e008110.

17.

Celebi

Yucel

Bulut

Kucuk

Balli

. Stenting of the ductus arteriosus in infants with functionally univentricular heart disease and ductal-dependent pulmonary blood flow: a single-center experience. Catheter Cardiovasc Interv. 2017;89(4):699–708.

18.

Meza

Prabhu

Chamberlain

Turek

Andersen

. Commentary: ductal stenting for ductal-dependent pulmonary blood flow: time for an exclusive club to expand its membership? J Thorac Cardiovasc Surg. 2020;S0022-5223(20):32223–32226.

19.

Qureshi

Goldstein

Glatz

, et al. Classification scheme for ductal morphology in cyanotic patients with ductal dependent pulmonary blood flow and association with outcomes of patent ductus arteriosus stenting. Catheter Cardiovasc Interv. 2019;93(5):933–943.

20.

Santoro

Gaio

Giugno

, et al. Ten-years, single-center experience with arterial duct stenting in duct-dependent pulmonary circulation: early results, learning-curve changes, and mid-term outcome. Catheter Cardiovasc Interv. 2015;86(2):249–257.

21.

Schranz

Michel-Behnke

Heyer

, et al. Stent implantation of the arterial duct in newborns with a truly duct-dependent pulmonary circulation: a single-center experience with emphasis on aspects of the interventional technique. J Interv Cardiol. 2010;23(6):581–588.

22.

Sivakumar

Bhagyavathy

Coelho

Satish

Krishnan

. Longevity of neonatal ductal stenting for congenital heart diseases with duct-dependent pulmonary circulation. Congenit Heart Dis. 2012;7(6):526–533.

23.

Glatz

Petit

Goldstein

, et al. Comparison between patent ductus arteriosus stent and modified Blalock-Taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: insights from the congenital catheterization research collaborative. Circulation. 2018;137(6):89–601.